Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03615599 · ClinicalTrials.gov registry record

Plant-based Diets and Risk of Cancer in the Adventist Health Study-2

A clinical trial of Cancer, Breast and Cancer Colorectal, sponsored by Loma Linda University.

Active
Registry status
96,000
Enrollment target
1
Study location

NCT03615599 is a study of Cancer, Breast and Cancer Colorectal that is active but no longer recruiting, run by Loma Linda University. The registered enrollment target is 96,000 participants, above the 468-participant average among 10 other Cancer, Breast trials with a reported enrollment target (20413% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03615599, a study of Cancer, Breast and Cancer Colorectal, is active but no longer recruiting, sponsored by Loma Linda University.

ACTIVE NOT RECRUITING
Registry status
96,000 participants
Enrollment target
1
Study location

Study Summary

The Adventist Health Study-2 is a long-term study, exploring the links between lifestyle, diet, and disease outcomes among Seventh-day Adventists. More than 96,000 church members from the U.S. and Canada are participating in the current study, AHS-2, conducted by researchers at the Loma Linda University School of Public Health.

Study Locations (1)

California

  • Loma Linda University - Loma Linda

Trial Details

FieldValue
Enrollment Target 96,000 participants
Start Date 2002-02-01
Est. Completion 2028-12

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT03615599

The ClinicalTrials.gov registry entry for NCT03615599 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 96,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 468-participant average among 10 other Cancer, Breast trials with a reported enrollment target (20413% higher). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer, Breast appearing as the primary indexed condition, and to 0 interventions.

NCT03615599 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03615599 about?

NCT03615599 is a clinical study titled "Plant-based Diets and Risk of Cancer in the Adventist Health Study-2". The Adventist Health Study-2 is a long-term study, exploring the links between lifestyle, diet, and disease outcomes among Seventh-day Adventists. More than 96,000 church members from the U.S. and Canada are participating in the current study, AHS-2, conducted by researchers at the Loma Linda Univer...

What is the current status of trial NCT03615599?

This trial is currently active not recruiting. The enrollment target is 96,000 participants. The study started on 2002-02-01. Estimated completion is 2028-12.

What conditions does trial NCT03615599 study?

This clinical trial studies the following conditions: Cancer, Breast, Cancer Colorectal, Cancer, Prostate.

Who is sponsoring clinical trial NCT03615599?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03615599 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer, Breast

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.